Skip to main content

Table 2 The frequency of immunohistochemical results of PACC

From: Pulmonary adenoid cystic carcinoma: molecular characteristics and literature review

Ref.

IHC result(No.of patients)

CK7

CD117

P63

SMA

CK5/6

S-100

TTF-1

CK20

CgA

CD56

Napsin A

[3]

NM

9/12

12/12

NM

NM

NM

4/12

NM

NM

NM

NM

[9]

11/11

NM

11/12

6/9

1/1

7/8

0/14

0/4

0/4

0/7

NM

[10]

1/1

2/2

0/2

NM

1/2

NM

0/2

NM

NM

0/1

NM

[11]

NM

20/20

20/20

20/20

NM

NM

0/20

NM

NM

NM

NM

[17]

1/1

1/1

0/1

NM

1/1

0/1

0/1

NM

NM

0/1

0/1

[29]

NM

33/34

NM

NM

NM

NM

NM

NM

NM

NM

NM

[30]

1/1

1/1

1/1

1/1

1/1

1/1

0/1

NM

NM

NM

NM

[31]

NM

NM

1/1

NM

1/1

NM

0/1

NM

0/1

0/1

0/1

[32]

1/1

1/1

1/1

NM

NM

NM

NM

NM

NM

NM

NM

Total

15/15

67/71

46/50

27/30

5/6

8/10

4/51

0/4

0/5

0/10

0/2

Rate

100%

94.4%

92.0%

90.0%

83.3%

80%

7.8%

0

0

0

0

  1. IHC results: Patients who express the biomarker/all patients who tested IHC in the reference (positive frequency). NM: not mention